ID27759A - Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi - Google Patents
Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasiInfo
- Publication number
- ID27759A ID27759A IDW20010663A ID20010663A ID27759A ID 27759 A ID27759 A ID 27759A ID W20010663 A IDW20010663 A ID W20010663A ID 20010663 A ID20010663 A ID 20010663A ID 27759 A ID27759 A ID 27759A
- Authority
- ID
- Indonesia
- Prior art keywords
- making
- benzoilguanidine
- derivates
- processes
- profitable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843489A DE19843489B4 (de) | 1998-09-22 | 1998-09-22 | Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27759A true ID27759A (id) | 2001-04-26 |
Family
ID=7881872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20010663A ID27759A (id) | 1998-09-22 | 1999-09-16 | Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP1165534B1 (cs) |
JP (1) | JP3817425B2 (cs) |
KR (1) | KR100621821B1 (cs) |
CN (1) | CN1166654C (cs) |
AR (1) | AR023668A1 (cs) |
AT (1) | ATE288425T1 (cs) |
AU (1) | AU764819C (cs) |
BG (1) | BG64985B1 (cs) |
BR (1) | BR9913107A (cs) |
CA (1) | CA2345006C (cs) |
CO (1) | CO5150207A1 (cs) |
CZ (1) | CZ300158B6 (cs) |
DE (2) | DE19843489B4 (cs) |
EA (1) | EA004687B1 (cs) |
EE (1) | EE04749B1 (cs) |
EG (1) | EG23757A (cs) |
ES (1) | ES2237951T3 (cs) |
HK (1) | HK1043367B (cs) |
HR (1) | HRP20010194B1 (cs) |
HU (1) | HU228955B1 (cs) |
ID (1) | ID27759A (cs) |
IL (1) | IL141805A (cs) |
MY (1) | MY121362A (cs) |
NO (1) | NO317993B1 (cs) |
NZ (1) | NZ511167A (cs) |
PE (1) | PE20001085A1 (cs) |
PL (1) | PL195291B1 (cs) |
PT (1) | PT1165534E (cs) |
RS (1) | RS49971B (cs) |
SA (1) | SA99200474B1 (cs) |
SK (1) | SK285578B6 (cs) |
TR (1) | TR200100801T2 (cs) |
TW (1) | TWI221841B (cs) |
WO (1) | WO2000017176A2 (cs) |
ZA (1) | ZA200101212B (cs) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10106970A1 (de) * | 2001-02-15 | 2002-08-29 | Boehringer Ingelheim Pharma | Neues Benzoylguanidinsalz |
US6730678B2 (en) * | 2001-02-15 | 2004-05-04 | Boehringer Ingelheim Pharma Kg | Benzoylguanidine salt and hydrates thereof |
US6982256B2 (en) | 2001-09-07 | 2006-01-03 | Boehringer Ingelheim Pharma Kg | Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration |
DE10144030A1 (de) * | 2001-09-07 | 2003-03-27 | Boehringer Ingelheim Pharma | Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin |
FR2871157A1 (fr) * | 2004-06-04 | 2005-12-09 | Aventis Pharma Sa | Produits biaryl aromatiques, compositions les contenant et utilisation |
WO2010005783A1 (en) * | 2008-07-08 | 2010-01-14 | Boehringer Ingelheim International Gmbh | Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
-
1998
- 1998-09-22 DE DE19843489A patent/DE19843489B4/de not_active Expired - Fee Related
-
1999
- 1999-08-17 SA SA99200474A patent/SA99200474B1/ar unknown
- 1999-09-16 BR BR9913107-2A patent/BR9913107A/pt not_active IP Right Cessation
- 1999-09-16 RS YUP-215/01A patent/RS49971B/sr unknown
- 1999-09-16 ID IDW20010663A patent/ID27759A/id unknown
- 1999-09-16 PT PT99952453T patent/PT1165534E/pt unknown
- 1999-09-16 AT AT99952453T patent/ATE288425T1/de active
- 1999-09-16 PL PL99347234A patent/PL195291B1/pl unknown
- 1999-09-16 EA EA200100317A patent/EA004687B1/ru not_active IP Right Cessation
- 1999-09-16 SK SK396-2001A patent/SK285578B6/sk not_active IP Right Cessation
- 1999-09-16 KR KR1020017003627A patent/KR100621821B1/ko not_active IP Right Cessation
- 1999-09-16 EE EEP200100178A patent/EE04749B1/xx not_active IP Right Cessation
- 1999-09-16 WO PCT/EP1999/006857 patent/WO2000017176A2/de active IP Right Grant
- 1999-09-16 IL IL14180599A patent/IL141805A/xx not_active IP Right Cessation
- 1999-09-16 CN CNB998111430A patent/CN1166654C/zh not_active Expired - Fee Related
- 1999-09-16 TR TR2001/00801T patent/TR200100801T2/xx unknown
- 1999-09-16 NZ NZ511167A patent/NZ511167A/en not_active IP Right Cessation
- 1999-09-16 HU HU0200225A patent/HU228955B1/hu not_active IP Right Cessation
- 1999-09-16 AU AU64659/99A patent/AU764819C/en not_active Ceased
- 1999-09-16 CZ CZ20011047A patent/CZ300158B6/cs not_active IP Right Cessation
- 1999-09-16 DE DE59911568T patent/DE59911568D1/de not_active Expired - Lifetime
- 1999-09-16 JP JP2000574086A patent/JP3817425B2/ja not_active Expired - Fee Related
- 1999-09-16 EP EP99952453A patent/EP1165534B1/de not_active Expired - Lifetime
- 1999-09-16 CA CA002345006A patent/CA2345006C/en not_active Expired - Fee Related
- 1999-09-16 ES ES99952453T patent/ES2237951T3/es not_active Expired - Lifetime
- 1999-09-20 PE PE1999000949A patent/PE20001085A1/es not_active Application Discontinuation
- 1999-09-20 MY MYPI99004064A patent/MY121362A/en unknown
- 1999-09-21 CO CO99059852A patent/CO5150207A1/es unknown
- 1999-09-22 AR ARP990104775A patent/AR023668A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 1999-09-22 TW TW088116279A patent/TWI221841B/zh not_active IP Right Cessation
- 1999-09-22 EG EG118099A patent/EG23757A/xx active
-
2001
- 2001-02-13 ZA ZA200101212A patent/ZA200101212B/en unknown
- 2001-03-09 BG BG105326A patent/BG64985B1/bg active Active
- 2001-03-15 HR HR20010194A patent/HRP20010194B1/xx not_active IP Right Cessation
- 2001-03-21 NO NO20011428A patent/NO317993B1/no not_active IP Right Cessation
-
2002
- 2002-07-08 HK HK02105065.7A patent/HK1043367B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL229509A0 (en) | Preparations containing chemically modified small molecules and processes using them | |
AU2003271498A8 (en) | Coolant solutions and compositions comprising the sameitle | |
IL164021A0 (en) | Antibodies and anti-pharmaceutical compositions containing the same | |
EP1661818A4 (en) | DISCHARGE BODY, DISCHARGE CONTAINER COMPRISING THE DISCHARGE BODY AND INSTILLATION CONTAINER | |
PL347500A1 (en) | Substituted 2-phenylbenzimidazoles, the production thereof and their use | |
BR9915457B1 (pt) | composições de moldagem, uso e artigo. | |
EP1617807A4 (en) | SUBSTITUTED 1,4-DIAZEPINE AND ITS USES | |
DE60211163D1 (de) | Rechnersystem mit dem Modemtreiber in privilegiertem Modus | |
ID29236A (id) | Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya | |
HUP0500639A3 (en) | Laundry additive composition, preparation and use thereof and detergent composition containing the same | |
GB0026054D0 (en) | Films,compositions and processes | |
MXPA03004932A (es) | 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe. | |
IL160913A0 (en) | Compositions useful as multisignal labeling reagents and processes utilizing the same | |
NO20010873D0 (no) | Mikropartikkel-blanding | |
NO20021376L (no) | Sikkerhetsventil nede i brönnen | |
SG98483A1 (en) | Heat-absorbing polymer composition | |
IS7140A (is) | Endurbætur við eða í sambandi við hjúpun | |
ID28343A (id) | Kaprolaktam tersubstitusi tertentu, komposisi farmasi yang mengandungnya dan penggunaannya dalam pengobatan tumor | |
ID27759A (id) | Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi | |
GB2374078B (en) | Organic anti-reflective coating polymers, anti-reflective coating composition comprising the same and preparation methods thereof | |
BR9902692B1 (pt) | copolìmero de silano, métodos para produção e cosméticos contendo o mesmo. | |
GB0000131D0 (en) | Thiolactomycin analogues,compositions containing the same and uses thereof | |
NO993998D0 (no) | Verktöy nede i brönnen | |
IL165551A0 (en) | Chromophores and methods utilizing the same | |
SG106681A1 (en) | Olefinic polymer and process for producing the same |